| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | C5INA23HXF |
| InChI Key | BJRNKVDFDLYUGJ-RMPHRYRLSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C12H16O7 |
| Molecular Weight | 272.25 |
| AlogP | -1.43 |
| Hydrogen Bond Acceptor | 7.0 |
| Hydrogen Bond Donor | 5.0 |
| Number of Rotational Bond | 3.0 |
| Polar Surface Area | 119.61 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 1.0 |
| Heavy Atoms | 19.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Tyrosinase inhibitor | PubMed |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Hydrolase
|
- | - | - | - | 7 | |
|
Enzyme
Oxidoreductase
|
- | 10400-100000 | - | - | 0-33 | |
|
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC21/SLCO family of organic anion transporting polypeptides
|
- | - | - | - | 104 |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Melanosis | 2 | D008548 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEBI | 18305 |
| ChEMBL | CHEMBL232202 |
| DrugBank | DB11217 |
| DrugCentral | 4267 |
| EPA CompTox | DTXSID7040152 |
| FDA SRS | C5INA23HXF |
| KEGG | C06186 |
| PubChem | 440936 |
| SureChEMBL | SCHEMBL36351 |
| ZINC | ZINC000000518554 |